相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy
Lei Du et al.
ACTA PHARMACOLOGICA SINICA (2021)
METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease
Zhaoxia Xu et al.
CELL DEATH & DISEASE (2021)
Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation
Hui Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial-to-Mesenchymal Transition in db/db Mice
Qilin Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Signaling Pathways Involved in Diabetic Renal Fibrosis
Yuqing Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells
Ya-Ning Wang et al.
BIOSCIENCE REPORTS (2020)
Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
Hong Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Timothy O. Adekoya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
Yudi Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Renal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis
Xiao-Tao Zhou et al.
PHARMACOLOGICAL RESEARCH (2020)
C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/-catenin and ERK signaling in streptozocin-induced diabetic nephropathy
Lin Zhang et al.
FASEB JOURNAL (2019)
PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease
Yajuan Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis
Dongdong Fu et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Nucleoside/Nucleobase-Rich Extract from Cordyceps Sinensis Inhibits the Epithelial-Mesenchymal Transition and Protects against Renal Fibrosis in Diabetic Nephropathy
Zhonghua Dong et al.
MOLECULES (2019)
Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
Yuyan Fan et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Projecting ESRD Incidence and Prevalence in the United States through 2030
Keith P. McCullough et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression
Yong Su et al.
PHARMACOLOGICAL REPORTS (2019)
Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis
Xiaolei Wang et al.
SCIENTIFIC REPORTS (2019)
Astragaloside IV inhibits TGF-1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-B pathway in gastric cancer cells
Jihong Zhu et al.
PHYTOTHERAPY RESEARCH (2018)
Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease
Mei Xue et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts
Sheng-Mou Hou et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway
Ting He et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy
Hengjiang Guo et al.
FRONTIERS IN PHARMACOLOGY (2016)
Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
Toshio Imai et al.
INFLAMMATION AND REGENERATION (2016)
Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study
Rachana Shah et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
Maria Vanessa Perez-Gomez et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
Jianguo Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice
K. H. Song et al.
DIABETOLOGIA (2013)
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy
Sharon N. Cox et al.
KIDNEY INTERNATIONAL (2012)
Tumor-promoting functions of transforming growth factor-β in progression of cancer
Kohei Miyazono et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy
L. Q. Meng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
Rachana Shah et al.
DIABETES (2011)
BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study
Eleni Makrodouli et al.
MOLECULAR CANCER (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways
Seon-Jin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli
Y Kikuchi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys
Y Kikuchi et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor κB- and p38 mitogen-activated protein kinase-dependent pathways
R Donadelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
分享论文
